Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects

NCT06567119 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Aging

Interventions

BIOLOGICAL: SPOT-mRNA01
OTHER: Placebo

Sponsor

SIPO Biotechnology Co. Ltd.

Collaborators

[object Object]